Dogness (International) Corporation
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsDogness (International) Corporation is a British Virgin Islands holding company that manufactures pet products through subsidiaries in China.
What they do
Dogness is a holding company whose operations are conducted through subsidiaries in Delaware, mainland China, Hong Kong, and the British Virgin Islands. It is listed on the NASDAQ Capital Market under the ticker DOGZ. The company is headquartered in Dongguan, Guangdong, People's Republic of China. Its common shares are registered under Section 12(b) of the Securities Exchange Act.
Revenue drivers
- Pet products manufacturing — The company generates revenue from manufacturing and selling pet products, though specifics are not detailed in the provided excerpts.
Recent performance
Revenue for fiscal 2025 was $20.7 million, up from $14.8 million in 2024. Net loss was $5.1 million, an improvement from a $6.1 million loss in 2024. Diluted EPS was -$0.38. Operating cash flow was $567,088. The company has reported net losses for three consecutive years.
Strategy
Management's strategy is not detailed in the provided excerpts. The company focuses on pet product manufacturing and has emphasized its corporate structure. No specific investments or priorities are outlined in the available text.
Risks
- Going concern — The company has stated that its ability to continue as a going concern is a risk factor.
- China operations — Investing in the company involves risks related to doing business in China, including economic conditions and government regulation.
- Competition and pricing — The company faces competition and pricing pressures that could impact results.
- Product demand — Changes in technology and product acceptance could affect demand for its products.
Outlook
The provided excerpts do not contain specific forward guidance. Management cautions that forward-looking statements are subject to risks and uncertainties. No specific outlook is given beyond the risks noted.